IL13 and allergic bronchopulmonary aspergillosis: For example, in the treatment of ABPA, it may be beneficial to use drugs that inhibit certain cytokines that are involved in the Th2 immune response, such as the antagonism of IL-5, IL-13, and chemokine CCR4, as well as modulation of the Th2 response towards Th1/Th17.